SCHEMBL4106733

SCHEMBL4106733

Cc1ccc(C(N)=O)cc1C(=O)Nc1ccc2[nH]cnc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.57
▸ NPC1 O15118 4/20 0.57
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ POLB P06746 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ HDAC1 Q13547 1/20 0.44
▸ HDAC8 Q9BY41 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ KIT P10721 4/20 0.43
▸ MAPT P10636 3/20 0.43
▸ KDR P35968 2/20 0.42
▸ MAPK14 Q16539 2/20 0.42
▸ CASP6 P55212 1/20 0.42
▸ CTDSP1 Q9GZU7 1/20 0.42
▸ LCK P06239 1/20 0.41
▸ AR P10275 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3993077 0.84 SMN1; SMN2 (0.48) RAB9ANPC1SMN1; SMN2POLBKMT2A
SCHEMBL13544523 0.78 RAB9A (0.52) RAB9ANPC1SMN1; SMN2POLBKMT2A
SCHEMBL6814638 0.77 QPCT (0.54) RAB9ANPC1SMN1; SMN2POLBKMT2A
SCHEMBL476588 0.77 AR (0.52) RAB9ASMN1; SMN2POLBKMT2AMEN1
SCHEMBL4600057 0.77 CHEK2 (0.58) RAB9ANPC1POLBKMT2AMEN1
Hydrochloric Acid SCHEMBL4541624 0.76 AR (0.51) RAB9ASMN1; SMN2POLBKMT2AMEN1
SCHEMBL2945530 0.74 KIT (0.64) KITKDRMAPK14LCK
SCHEMBL5265934 0.74 NAMPT (0.51) RAB9ANPC1SMN1; SMN2POLBKMT2A
SCHEMBL13373496 0.74 RAB9A (0.62) RAB9ANPC1SMN1; SMN2POLBKMT2A
SCHEMBL3588579 0.73 RAB9A (0.47) RAB9ANPC1SMN1; SMN2POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064213-A1 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2009-06-03 — — EP claimed
WO-2008028617-A1 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-13 — — WO claimed
EP-2064213-A1 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2009-06-03 — — EP disclosed
WO-2008028617-A1 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-13 — — WO disclosed
Send feedback